Search

everythinglearnresearchcommunity

for

Search:↓

Transplant patients face higher skin cancer risks due to immunosuppressive therapy, requiring careful skin health monitoring.

Hair follicle stem cells reduced hair loss and inflammation in mice with a condition similar to human alopecia.

Using mesenchymal stem cells or their exosomes is safe for COVID-19 patients and helps improve lung healing and oxygen levels.

Mesenchymal stem cells show promise for effective skin repair and regeneration.

Protein tyrosine kinases are key in male pattern baldness, affecting skin structure, hair growth, and immune responses.

Wharton’s Jelly stem cells from the umbilical cord improve skin healing and hair growth without scarring.

Horse skin stem cells combined with platelet-rich plasma improve skin healing.

Manipulating cell cleanup processes could help treat hair loss.

Hair loss can indicate underlying systemic diseases and addressing these can sometimes reverse the hair loss.

An elderly woman with cancer improved after treatment for a rare skin condition with coiled hairs.

Two teenage brothers had a rare, treatment-resistant form of female-pattern hair loss with unusual scalp changes.

Unconventional lymphocytes are important for quick immune responses and healing of skin and mucosal barriers.

Skin issues can indicate immune system problems.

The secretome from mesenchymal stem cells is a promising treatment that may repair tissue and avoid side effects of stem cell transplantation.

Cicatricial alopecia, a permanent hair loss condition, is mainly caused by damage to specific hair follicle stem cells and abnormal immune responses, with gene regulator PPAR-y and lipid metabolism disorders playing significant roles.

Hair follicles help attract immune cells to the skin during stress.

Conditioned media from mesenchymal stem cell cultures could be a more effective alternative for regenerative therapies, but more research is needed.

Mesenchymal stem cells show potential for skin healing and anti-aging, but more research is needed for safe use, especially regarding stem cells from induced pluripotent sources.

Inflammation and Demodex mites might contribute to hair loss, and targeting them could help treat it.

Phototherapy can help treat hair loss in alopecia areata.

People with allergies or high eosinophil levels have a higher chance of severe hair loss from alopecia areata, and sudden hair loss can indicate chronic graft-versus-host disease.

A woman's hair loss from graft versus host disease helps understand similar hair loss conditions.

A woman's sudden hair loss three years after a bone marrow transplant was a sign of chronic graft-versus-host disease but improved with treatment.

ATIR101 improves survival in stem cell transplant patients; Australian stem cell treatment decisions are influenced by regulation changes.

Busulfan/cyclophosphamide and total bone irradiation are equally effective for AML transplants.

Patients with chronic graft-versus-host disease often have skin problems like vitiligo and alopecia areata.

Mice with human fetal thymic tissue and stem cells developed symptoms similar to chronic graft-versus-host disease.

Ruxolitinib may help treat hair loss and symptoms in patients with chronic graft-versus-host disease.

Skin changes help detect graft-versus-host reaction early after bone marrow transplants.

Permanent hair loss after bone marrow transplant can be caused by chemotherapy or chronic graft-versus-host disease.